AIDS Clinical Trials Group Spotlights on Amita Gupta

Date: 02/19/2015

Publication:

ACTG Spotlight

The AIDS Clinical Trials Group (ACTG) Network recognizes researchers and staff actively doing great work.  Spotlight highlights Dr. Gupta’s work in TB research in India.

Meet Amita Gupta

As a child, Amita Gupta, MD, witnessed infectious diseases firsthand while visiting extended family in India.

“I spent summers in India and saw the effects of polio, hepatitis B, tuberculosis and malaria,” she says. “Then when I was in college, I was galvanized by the world of HIV activism. I found myself more and more interested in working on HIV, volunteering at AIDS Action and Fenway Health in Boston. I later worked on HIV/AIDS at the Massachusetts Health Department.”

Read the complete article.
 

Clinical Trials

A5342: Evaluating the Safety, Tolerability, and Effect of a...

The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...

Read More

HPTN083: A Phase 2b/3 Double Blind Safety and Efficacy Study...

HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...

Read More

A5273: Multicenter Study of Options for Second-Line...

The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...

Read More

A5128: Consent for Use of Stored Patient Specimens for...

The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...

Read More

A5253: Sensitivity and Specificity of Mycobacterium...

An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...

Read More